Other Cancers Investigating Savolitinib and Durvalumab in Metastatic Papillary Renal Cancer Jun 02, 2023
Genitourinary Cancer,RCC (Renal Cell Carcinoma) Pembrolizumab Plus Lenvatinib as First-Line Treatment for nCRCC Jun 02, 2023
Gastrointestinal Cancer,Other Cancers Pembrolizumab Plus Chemotherapy vs. Chemotherapy Alone for Advanced Oesophageal Cancer Jun 01, 2023
Colorectal Cancer,Gastrointestinal Cancer Nivolumab Plus Low-Dose Ipilimumab as First-Line Treatment for mCRC Jun 01, 2023
Breast Cancer,Other Cancers Neratinib's Antitumour Activity in HER2-Mutant Advanced BTCs Jun 01, 2023
Breast Cancer Combining Forces: Maximizing Chemotherapy Efficacy in Node-Positive Breast Cancer Jun 01, 2023
Breast Cancer Exposure-Response Relationships in HER2+ Breast Cancer with Trastuzumab Deruxtecan Jun 01, 2023
Other Cancers KTE-X19 Outcomes in Relapsed/Refractory Mantle Cell Lymphoma in ZUMA-2 Study Jun 01, 2023
